The past two decades have witnessed immense progress in synthetic biology, including development of tools for genetic manipulation, elucidation of design principles for designing robust gene circuits, tools to analyze dynamics of engineered cells, and application of engineered cells in diverse contexts. A Cold Spring Harbor Asia Conference on Synthetic Biology was held in Suzhou China, in November 2016, to showcase a subset of such developments.
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The past two decades have witnessed immense progress in synthetic biology, including development of tools for genetic manipulation, elucidation of design principles for designing robust gene circuits, tools to analyze dynamics of engineered cells, and application of engineered cells in diverse contexts. A Cold Spring Harbor Asia Conference on Synthetic Biology was held in Suzhou China, in November 2016, to showcase a subset of such developments.
To highlight these progresses, the Biotechnology Journal invited a number of review research articles to form the basis of a special issue on Synthetic Biology.
These articles illustrate the progress in multiple aspects. For example, it is well appreciated that a major application arm for synthetic biology is in the engineering of metabolic pathways for producing valuable products. In this framework, Okano and colleagues [1] engineer the Lactobacillus plantarum NCIMB 8826 to enhance production of optically pure L-lactic acid from raw starch by deletion of lactate dehydrogenase, and the operon encoding lactate racemase (larA-E), and furthermore introduced the alpha-amylase from Streptococcus bovis 148 to increase the production level and to obtain 98.6% of optically pure lactic acid. Liu and colleagues [2] use rational metabolic engineering to increase L-cysteine production by 14-fold in Escherichia coli by modifying transport, sulfur supply, enhance precursor pathway, and reduce L-cysteine degradation.
Interestingly, Thomson and coworkers [3] dissect the quiescent (Q-Cell) E. coli, known to have enhanced production of 3hydroxybutyrate, for its proteomics and metabolomics. This analysis has made it possible for the potential use of Q-cells as a production host for a wide range of chemical compounds. Similarly, Hirasawa and colleagues [4] have analyzed the transcriptome and metabolome of Corynebacterium glutamicum to understand the mechanism of penicillin-induced glutamic acid production. Another way to examine the metabolism of a production host is by perturbation of a metabolic steady-state and the detailed analysis of the subsequent metabolic response. Tröndle and coworkers [5] perturb the supply of substrate (e.g., phosphoenolpyruvate) in E. coli to understand its impact on Lphenylalanine production and identified substrate transporters as important aspects to consider. Importantly, this method can be applied to other compound processes.
The engineering of diverse gene circuits depends on the development of well characterized parts and devices and the corresponding chassis cells. To this end, McCutcheon and colleagues [6] demonstrate the development of a set of CRISPR-Cas-based devices for tunable control of gene expression. Aparicio and colleagues [7] use a CRISPR-Cas9 system to enable effective genetic engineering of Pseudomonas putida, which is emerging as an increasingly popular cell-factory platform for metabolic engineering and recombinant protein synthesis.
Microfluidics has become an indispensable tool in quantitative analysis of single cells or cell populations. It is also instrumental in demonstrating some of the pioneering gene circuits in the field. Bai and colleagues [8] review various microfluidic technologies, with a particular focus on their application in the analysis engineered cell dynamics.
It has been well appreciated that "designer cells," programmed by well-defined gene circuits, have great potential in medicine. Wang and colleagues [9] discuss the recent progress and challenges in engineering mammalian cells for the treatment of metabolic diseases. In a same spirit but completely different context, Dou and Bennett [10] discuss how synthetic biology can play a pivotal role in precise control of the gut microbiome dynamics, for health and medical applications.
While gene circuits have been primarily engineered toward to the programming of single populations, the relevance of understanding and controlling dynamics of mixed populations is increasingly appreciated. Li and colleagues [11] demonstrate the engineering of a microbial consortia as the foundation for highperformance microbial fuel cells.
We hope this special issue will provide the readers a glimpse of recent, exciting developments in synthetic biology.
